{"id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(rel.disease_name) CONTAINS 'ovarian' AND\n  toLower(rel.disease_name) CONTAINS 'serous' AND\n  toLower(rel.disease_name) CONTAINS 'carcinoma'\n)\nAND (\n    toLower(rel.effect) = 'resistance'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "AURKA", "therapy_name": "Platinum Compound", "effect": "resistance", "disease_name": "Ovarian Serous Carcinoma", "pmids": ["27209210"]}], "error": null}
{"id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t.name) CONTAINS toLower('Dasatinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "BCR", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Cancer", "pmids": ["18191450"]}, {"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Cancer", "pmids": ["25317746"]}], "error": null}
{"id": "F4.1-000047-P1", "question": "What drugs targeting ALK have biomarker evidence in Diffuse Large B-cell Lymphoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nWITH\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Variant THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE variant_name IS NOT NULL\nUNWIND pmids AS p\nWITH variant_name, gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "generated_rows": [{"variant_name": null, "gene_symbol": null, "therapy_name": "Crizotinib", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "error": null}
{"id": "F4.1-000096", "question": "Which therapies target ALK and also have biomarker evidence in Glioblastoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Variant THEN b.symbol ELSE NULL END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "generated_rows": [{"variant_name": "ALK Expression", "gene_symbol": null, "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": null, "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": null, "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": null, "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": null, "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "error": null}
{"id": "F2.2-000185-S1", "question": "How does the variant RPS6 PHOSPHORYLATION affect response to Everolimus in Adenocarcinoma Of Stomach?", "gold_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RPS6 PHOSPHORYLATION", "gene_symbol": "RPS6", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22343617"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000012-S1-P3", "question": "Show treatments for TOP1 excluding HDAC1 that have biomarker evidence in Ureteral Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(otherGene:Gene)\nWHERE toLower(otherGene.symbol) <> toLower('TOP1')\n   AND toLower(otherGene.symbol) <> toLower('HDAC1')\nWITH t, g, otherGene\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureteral' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000094", "question": "What therapies target TOP1 but NOT PSMA1, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000027-P1", "question": "Which drugs hit TOP1 but not SRD5A3 with evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('SRD5A3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('SRD5A3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('SRD5A3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('SRD5A3'))\nWITH t, g, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE 'TOP1' END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000167-P3", "question": "Show treatments for TOP1 excluding POLD3 that have biomarker evidence in Ureter Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE 'TOP1' END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000082", "question": "List therapies with variant-level biomarkers in Diffuse Large B-cell Lymphoma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(rel.disease_name) CONTAINS 'diffuse' AND\n  toLower(rel.disease_name) CONTAINS 'large' AND\n  toLower(rel.disease_name) CONTAINS 'b-cell' AND\n  toLower(rel.disease_name) CONTAINS 'lymphoma'\n)\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN v:Gene THEN v.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["21494621"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584"]}, {"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35380993"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "PIM1 L2V", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 P81S", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 S97N", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "MS4A1 Mutation", "gene_symbol": "MS4A1", "therapy_name": "R-CHOP Regimen", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32589730"]}, {"variant_name": "TMEM30A loss-of-function mutation", "gene_symbol": "TMEM30A", "therapy_name": "R-CHOP Regimen", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32094924"]}, {"variant_name": "EZH2 Y646H", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29650362"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584", "28835384"]}, {"variant_name": "EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["34159682"]}, {"variant_name": "EZH2 expression", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma Germinal Center B-cell Type", "pmids": ["33492746"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Venetoclax", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29463802"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "CLTC", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["21494621"]}, {"variant_name": null, "gene_symbol": "EZH2", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584"]}, {"variant_name": null, "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}, {"variant_name": null, "gene_symbol": "EZH2", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35380993"]}, {"variant_name": null, "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": null, "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": null, "gene_symbol": "MS4A1", "therapy_name": "R-CHOP Regimen", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32589730"]}, {"variant_name": null, "gene_symbol": "TMEM30A", "therapy_name": "R-CHOP Regimen", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32094924"]}, {"variant_name": null, "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29650362", "35151584", "28835384", "34159682"]}, {"variant_name": null, "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma Germinal Center B-cell Type", "pmids": ["33492746"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Venetoclax", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29463802"]}], "error": null}
{"id": "F1.1-000036-P1", "question": "Which therapies target TUBA3C?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TUBA3C')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TUBA3C'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TUBA3C')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TUBA3C'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  t.moa AS targets_moa,\n  coalesce(t.ref_sources, []) AS ref_sources,\n  coalesce(t.ref_ids, []) AS ref_ids,\n  coalesce(t.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"therapy_name": "Cabazitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "Taxane"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "http://en.wikipedia.org/wiki/Taxane"]}, {"therapy_name": "Docetaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["FDA", "Wikipedia"], "ref_ids": ["label/2014/201195s006lbl.pdf", "Microtubule"], "ref_urls": ["http://en.wikipedia.org/wiki/Microtubule", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf"]}, {"therapy_name": "Enfortumab Vedotin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["Other", "PubMed", "PubMed", "PubMed"], "ref_ids": ["http://www.seattlegenetics.com/pipeline/enfortumab-vedotin", "27013195", "27518442", "28353637"], "ref_urls": ["http://europepmc.org/abstract/MED/27013195", "http://europepmc.org/abstract/MED/27518442", "http://europepmc.org/abstract/MED/28353637", "http://www.seattlegenetics.com/pipeline/enfortumab-vedotin"]}, {"therapy_name": "Eribulin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "22619477"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "http://europepmc.org/abstract/MED/22619477"]}, {"therapy_name": "Paclitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Taxol", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Trastuzumab Emtansine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "DailyMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "1241159", "22044006", "23798344"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "http://europepmc.org/abstract/MED/1241159", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/23798344"]}, {"therapy_name": "Vincristine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "22044006"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "http://europepmc.org/abstract/MED/22044006"]}, {"therapy_name": "Vinorelbine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "22044006", "22594474"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/22594474"]}], "generated_rows": [{"therapy_name": "Cabazitaxel", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Docetaxel", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Enfortumab Vedotin", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Eribulin", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Paclitaxel", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Taxol", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Trastuzumab Emtansine", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Vincristine", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}, {"therapy_name": "Vinorelbine", "gene_symbol": "TUBA3C", "targets_moa": null, "ref_sources": [], "ref_ids": [], "ref_urls": []}], "error": null}
{"id": "F5.1-000158-P1", "question": "Which biomarkers show evidence in Glioblastoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  OR any(s IN coalesce(rel.synonyms, []) WHERE toLower(s) CONTAINS 'glioblastoma')\n)\nRETURN\n  b.symbol AS biomarker_gene,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "3-Dimensional Conformal Radiation Therapy", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Adavosertib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification AND EGFR EGFRVIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26423602"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR EGFR::WIF1 Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "IDH-wildtype Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "VEGFA Overexpression", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["18182667"]}, {"variant_name": "VEGFA Overexpression of VEGF121", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["29747600"]}, {"variant_name": "EGFR EGFR::VSTM2A Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab/Lomustine Regimen", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PIK3R1 Mutation", "gene_symbol": "PIK3R1", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Carmustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "IDH1 R132", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "IDH1 R132S", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Dacomitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25939761"]}, {"variant_name": "DRD5 low expression", "gene_symbol": "DRD5", "therapy_name": "Dordaviprone", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30559168"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "FGFR1 FGFR1::TACC1 Fusion", "gene_symbol": "FGFR1", "therapy_name": "Futibatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34551969"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "ROS1 Overexpression", "gene_symbol": "ROS1", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25978031"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "KANK1 KANK1::NTRK2 Fusion", "gene_symbol": "KANK1", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34041811"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25730903"]}, {"variant_name": "HGF EXPRESSION", "gene_symbol": "HGF", "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22203985"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "Navtemadlin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Nimotuzumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "PMS2 K706FS*19", "gene_symbol": "PMS2", "therapy_name": "Nivolumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27001570"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Nivolumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "O6-Benzylguanine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "CDK6 Amplification", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "CDK6 Overexpression", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma Proneural Subtype", "pmids": ["28903422"]}, {"variant_name": "CDKN2A Loss", "gene_symbol": "CDKN2A", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22711607"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "IDH1 R132H", "gene_symbol": "IDH1", "therapy_name": "Pan-Mutant-IDH1 Inhibitor Bay-1436032", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21045145"]}, {"variant_name": "POLE Mutation", "gene_symbol": "POLE", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27683556"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Pembrolizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Pexidartinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Pyridostatin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Rindopepimut", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25586468"]}, {"variant_name": "KIT EXPRESSION", "gene_symbol": "KIT", "therapy_name": "Sunitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24311637"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31852834"]}, {"variant_name": "ATM Mutation", "gene_symbol": "ATM", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23960094"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "MGMT RS16906252", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25910840"]}, {"variant_name": "MGMT Underexpression", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21331613"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Vatalanib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24725538"]}], "generated_rows": [{"biomarker_gene": null, "therapy_name": "3-Dimensional Conformal Radiation Therapy", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"biomarker_gene": null, "therapy_name": "Adavosertib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"biomarker_gene": null, "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26423602"]}, {"biomarker_gene": null, "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "IDH-wildtype Glioblastoma", "pmids": ["26762204"]}, {"biomarker_gene": null, "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"biomarker_gene": null, "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["18182667"]}, {"biomarker_gene": null, "therapy_name": "Bevacizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["29747600"]}, {"biomarker_gene": null, "therapy_name": "Bevacizumab/Lomustine Regimen", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"biomarker_gene": null, "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"biomarker_gene": null, "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"biomarker_gene": null, "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"biomarker_gene": null, "therapy_name": "Carmustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"biomarker_gene": null, "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"biomarker_gene": null, "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"biomarker_gene": null, "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"biomarker_gene": null, "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"biomarker_gene": null, "therapy_name": "Dacomitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25939761"]}, {"biomarker_gene": null, "therapy_name": "Dordaviprone", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30559168"]}, {"biomarker_gene": null, "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"biomarker_gene": null, "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"biomarker_gene": null, "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"biomarker_gene": null, "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"biomarker_gene": null, "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Futibatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34551969"]}, {"biomarker_gene": null, "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"biomarker_gene": null, "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25978031"]}, {"biomarker_gene": null, "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"biomarker_gene": null, "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34041811"]}, {"biomarker_gene": null, "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"biomarker_gene": null, "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"biomarker_gene": null, "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}, {"biomarker_gene": null, "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25730903"]}, {"biomarker_gene": null, "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22203985"]}, {"biomarker_gene": null, "therapy_name": "Navtemadlin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"biomarker_gene": null, "therapy_name": "Nimotuzumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"biomarker_gene": null, "therapy_name": "Nivolumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27001570"]}, {"biomarker_gene": null, "therapy_name": "Nivolumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"biomarker_gene": null, "therapy_name": "O6-Benzylguanine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"biomarker_gene": null, "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"biomarker_gene": null, "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"biomarker_gene": null, "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"biomarker_gene": null, "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"biomarker_gene": null, "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma Proneural Subtype", "pmids": ["28903422"]}, {"biomarker_gene": null, "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22711607"]}, {"biomarker_gene": null, "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"biomarker_gene": null, "therapy_name": "Pan-Mutant-IDH1 Inhibitor Bay-1436032", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21045145"]}, {"biomarker_gene": null, "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27683556"]}, {"biomarker_gene": null, "therapy_name": "Pembrolizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"biomarker_gene": null, "therapy_name": "Pexidartinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"biomarker_gene": null, "therapy_name": "Pyridostatin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"biomarker_gene": null, "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"biomarker_gene": null, "therapy_name": "Rindopepimut", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25586468"]}, {"biomarker_gene": null, "therapy_name": "Sunitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24311637"]}, {"biomarker_gene": null, "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"biomarker_gene": null, "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31852834"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23960094"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25910840"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21331613"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"biomarker_gene": null, "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"biomarker_gene": null, "therapy_name": "Vatalanib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"biomarker_gene": null, "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24725538"]}], "error": null}
{"id": "F5.1-000175", "question": "In Malignant Anus Melanoma, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'anus' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(rel.disease_name) CONTAINS 'anal' AND\n  toLower(rel.disease_name) CONTAINS 'melanoma'\n)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "KIT Internal Duplication", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "sensitivity", "disease_name": "Malignant Anus Melanoma", "pmids": ["18421059"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000018-P3", "question": "What biomarkers have therapy response evidence in B-cell Non-Hodgkin Lymphoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'non-hodgkin' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(rel.disease_name) CONTAINS 'b-cell' AND\n  toLower(rel.disease_name) CONTAINS 'non-hodgkin' AND\n  toLower(rel.disease_name) CONTAINS 'lymphoma'\n)\nRETURN\n  b.symbol AS biomarker_gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}, {"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Galiximab", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}], "generated_rows": [{"biomarker_gene_symbol": null, "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}, {"biomarker_gene_symbol": null, "therapy_name": "Galiximab", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}], "error": null}
{"id": "F6.4-000173-S1", "question": "For resistance to MUC1-targeted Peptide GO-203-2C in Non-small Cell Lung Carcinoma, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('MUC1-targeted Peptide GO-203-2C')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('MUC1-targeted Peptide GO-203-2C'))\n  OR toLower(t1.name) CONTAINS toLower('MUC1-targeted Peptide GO-203-2C')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('MUC1-targeted Peptide GO-203-2C')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant {name: 'GO-203-2C'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MUC1-targeted Peptide GO-203-2C')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MUC1-targeted Peptide GO-203-2C'))\n  OR toLower(t.name) CONTAINS toLower('MUC1-targeted Peptide GO-203-2C')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000019-S1-P3", "question": "What genes are sensitivity biomarkers for Pictilisib in Malignant Neoplasm Of Breast?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22802530"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058", "23888070"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22802530"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["23888070", "20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "error": null}
{"id": "F2.2-000038-S1-P2", "question": "Which genes influence response to Vemurafenib for Childhood Ganglioglioma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'childhood' AND\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": null, "disease_name": "Ganglioglioma", "pmids": ["26579623", "31985841", "30120137"]}], "generated_rows": [], "error": null}
{"id": "F3.3-000140", "question": "Which drugs target TOP1 but not TUBA4A?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('TUBA4A')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('TUBA4A'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('TUBA4A')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('TUBA4A'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE 'Unknown' END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "generated_rows": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "Unknown", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "Unknown", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "TACSTD2 T256R", "gene_symbol": "Unknown", "therapy_name": "Sacituzumab Govitecan", "effect": "resistance", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["34404686"]}, {"variant_name": "TOP1 E418K AND TOP1 -122fs", "gene_symbol": "Unknown", "therapy_name": "Sacituzumab Govitecan", "effect": "resistance", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["34404686"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "Unknown", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["31047803"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "Unknown", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "Unknown", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Stomach Cancer", "pmids": ["31047804"]}], "error": null}
{"id": "F3.3-000188-P2", "question": "List treatments targeting TOP1 and not EPHA3.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('EPHA3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('EPHA3'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('EPHA3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('EPHA3'))\nWITH t, g, gx\nWHERE gx IS NULL\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'targeting' AS effect,\n  'disease_name' AS disease_name,\n  NULL AS pmids,\n  NULL AS moa,\n  NULL AS ref_sources,\n  NULL AS ref_ids,\n  NULL AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "targeting", "disease_name": "disease_name", "pmids": [], "moa": null, "ref_sources": null, "ref_ids": null, "ref_urls": null}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "effect": "targeting", "disease_name": "disease_name", "pmids": [], "moa": null, "ref_sources": null, "ref_ids": null, "ref_urls": null}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "targeting", "disease_name": "disease_name", "pmids": [], "moa": null, "ref_sources": null, "ref_ids": null, "ref_urls": null}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "effect": "targeting", "disease_name": "disease_name", "pmids": [], "moa": null, "ref_sources": null, "ref_ids": null, "ref_urls": null}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "effect": "targeting", "disease_name": "disease_name", "pmids": [], "moa": null, "ref_sources": null, "ref_ids": null, "ref_urls": null}], "error": null}
{"id": "F6.2-000056-P1", "question": "Which drugs hit TOP1 but not KDR with evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('KDR')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('KDR'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('KDR')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('KDR'))\nWITH t, g, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE 'TOP1' END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000127", "question": "What therapies target TOP1 but NOT PSMD6, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMD6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMD6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMD6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMD6'))\nWITH t, g, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE 'TOP1' END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [], "error": null}
